Metabolic
Tirzepatide
Clinically approved
4.70 reviewsPrimary purposes
Fat loss, Blood sugar control
Relevant conditions
Type 2 diabetes, Obesity
Mechanism of action
Dual GIP and GLP-1 receptor agonist.
Details
In the SURMOUNT trials tirzepatide showed average weight loss above 20%. Approved for diabetes and obesity. Requires a prescription.
Verified sources & manufacturers
Coming soon – we are building a list of verified studies and manufacturers. Learn more
Community experiences
Sign in to write reviews and share experiences.
No reviews yet – be the first.